Cansortium Reports Preliminary Unaudited Q4/FY 2021 and Q1 2022 Results – FY 2021 Revenue up 22% YoY to $63.7 Million; Adjusted EBITDA up 90% YoY to $19.6 million – Q4 2021 Revenue up 13% YoY to $16.5 Million; Adjusted EBITDA up 55% YoY to $5.1 million – Preliminary Q1 2022 Revenue up 33% YoY to […]
READ MORE: https://www.newcannabisventures.com/cansortium-q4-revenue-increases-6-sequentially-to-16-5-million/
[Original Source]
